Group Leader, Associate Director in AI-Based Antibody Drug Discovery
BeiGene
Summary
At BeOne Institute, we extend BeOne's execution strength with a dedicated innovation engine, bringing agility and scientific depth to transform uncertainty into actionable and high-impact therapeutic opportunities. We operate according to three core principles: Bold Exploration, Strategic Alignment, and Pipeline Impact.
Job description
General Description
At BeOne Institute, we extend BeOne's execution strength with a dedicated innovation engine, bringing agility and scientific depth to transform uncertainty into actionable and high-impact therapeutic opportunities. We operate according to three core principles: Bold Exploration, Strategic Alignment, and Pipeline Impact.
As an Associate Group Leader at BeOne Institute, you will help lead a high-performing research team to advance breakthrough discoveries. You will set and execute a forward-looking research strategy aligned with our mission, foster a collaborative environment where innovative ideas are translated into transformative medicines.
Job Responsibilities
- Drive scientific excellence and delivery by establishing clear program goals and milestones.
- Communicate progress through regular updates while proactively identifying challenges and proposing solutions.
- Support the Group Leader, BeOne Institute and build and develop a high performing team and foster team members professional growth, technical expertise and scientific expertise.
- Lead cross-disciplinary or cross-functional collaborations and drive innovation within and beyond the Institute.
- Contribute to the development of research strategy and ensure effective execution within defined therapeutic area or technology space.
- Provide scientific guidance and influence decision-making within own research group, while contributing to broader discussions across the organization.
Supervisory Responsibilities
Build and manage a team of scientists and/or lead project based teams.
Requirements
- Ph.D., M.D., or equivalent advanced degree with deep expertise in cancer biology, cancer immunology, immunology, protein engineering, AI-driven protein design, or a related life sciences discipline
- 8+ years of relevant post-degree experience, including postdoctoral and/or industry research experience
- Strong track record of contributions to antibody drug discovery or impactful scientific achievements
- Experience with antibody design and generation
- Ability to operate effectively in a highly collaborative, fast-paced, and interdisciplinary research environment
- Ability to integrate multi-disciplinary approaches to solve complex biological problems
- Demonstrated scientific leadership and potential to lead a research group
- Ability to influence cross-functional collaborations
- Experience providing guidance and mentorship, supporting development of team members
- Strong communication and presentation skills
- Ability to clearly articulate complex scientific concepts to diverse audiences
- Experience/deep knowledge with AI based antibody discovery preferred
Benefits
- Medical, Dental & Vision
- 401(k)
- FSA/HSA
- Life Insurance
- Paid Time Off
- Wellness
- Annual bonus plan
- Discretionary equity awards
- Employee Stock Purchase Plan
Company overview
BeiGene, Ltd., now rebranding as BeOne Medicines, is a global commercial-stage biotechnology company specializing in the discovery, development, manufacturing, and commercialization of innovative oncology medicines. Founded in 2010 by John V. Oyler and Xiaodong Wang, the company has grown into a multinational organization with headquarters in Cambridge, Massachusetts, Beijing, China, and Basel, Switzerland. BeiGene focuses on developing targeted and immune-oncology therapies for cancer treatment, with a diverse pipeline that includes internally discovered products like BRUKINSA (zanubrutinib), a Bruton's tyrosine kinase inhibitor, and Tevimbra (tislelizumab), a PD-1 inhibitor. The company operates across six continents with over 45 countries participating in clinical trials and has enrolled more than 30,000 patients in its research programs. With approximately 12,000 employees worldwide, BeiGene has established itself as a significant player in global oncology, particularly with strong market presence in China and expanding operations in the United States and Europe. The company's mission centers on expanding access to high-quality cancer therapies worldwide through persistent innovation and challenging traditional approaches to drug development.